Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Thiotepa and Methotrexate in Breast Cancer With Leptomeningeal Metastasis
NCT06543992Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, methotrexate in leptomeningeal metastasis (LM), sponsored by Jiangsu Provincial People's Hospital. Started Aug 2024; status: recruiting.
02
Drugs
thiotepamethotrexate
03
Conditions
leptomeningeal metastasis (LM)
Beyond the preview
Go deeper on NCT06543992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06543992.